Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/8622 stock hub

HKG/8622 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/8622is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

170.1M

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/8622

In the news

Latest news · HKG/8622

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-9.5

P25 -14.7P50 2P75 9.4

ROIC-52

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/8622 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

CNY

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	101
Employees Change	10%
Employees Change Percent	10.99
Enterprise value	HKD 130.1M
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG4644W1069
Last refreshed	2026-05-10
Market cap	HKD 170.1M
Price	HKD 0.33
Price currency	HKD
Rev Per Employee	311,608.9x
Sector	Healthcare
Sic	2836
Symbol	hkg/8622
Website	https://joyzymebiotech.com/en/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.27%
EV Earnings	-23.35x
EV/FCF	-30.01x
EV/Sales	4.13x
FCF yield	-2.55%
P/B ratio	2.99x
P/S ratio	5.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-27.9%
EBITDA Margin	-21.82%
Gross margin	62.83%
Gross Profit	HKD 19.8M
Gross Profit Growth	1.54%
Gross Profit Growth Q	2.97%
Gross Profit Growth3 Y	2.42%
Gross Profit Growth5 Y	1.12%
Net Income	HKD -5.6M
Net Income Growth Years	0%
Pretax Margin	-17.73%
Profit Margin	-17.7%
Profit Per Employee	HKD -55,156
ROA	-7.48
Roa5y	-5.38
ROCE	-15.22
ROE	-9.53
Roe5y	-8.13
ROIC	-51.99
Roic5y	-26.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-15.39%
Cagr3y	21.49%
Cagr5y	28.56%
EPS Growth Years	0
Revenue Growth	11.53x
Revenue Growth Q	18.69x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	4.08x
Revenue Growth5 Y	2.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.43
Assets	HKD 74.1M
Cash	HKD 46.7M
Current Assets	HKD 65.9M
Current Liabilities	HKD 17M
Debt	HKD 6.6M
Debt Equity	HKD 0.12
Debt FCF	HKD -1.53
Equity	HKD 56.9M
Interest Coverage	-32.08
Liabilities	HKD 17.2M
Long Term Assets	HKD 8.2M
Long Term Liabilities	HKD 206,096
Net Cash	HKD 40M
Net Cash By Market Cap	HKD 23.54
Net Cash Growth	11%
Net Debt Equity	HKD -0.7
Tangible Book Value	HKD 56.9M
Tangible Book Value Per Share	HKD 0.11
WACC	8.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.88
Inventory Turnover	3.53
Net Working Capital	HKD 6.5M
Quick ratio	3.56
Working Capital	HKD 47.3M
Working Capital Turnover	HKD 0.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-15.38%
200-day SMA	0.39
3Y total return	79.35%
50-day SMA	0.33
50-day SMA vs 200-day SMA	50under200
5Y total return	251.06%
All Time High	0.75
All Time High Change	-56%
All Time High Date	2025-10-31
All Time Low	0.08
All Time Low Change	312.5%
All Time Low Date	2024-06-05
ATR	0.01
Beta	0.78
Beta1y	-0.19
Beta2y	0.43
Ch YTD	-24.14
High	0.33
High52	0.75
High52 Date	2025-10-31
High52ch	-56%
Low	0.32
Low52	0.29
Low52 Date	2025-07-15
Low52ch	15.79%
Ma50ch	0.03%
Price vs 200-day SMA	-16.31%
RSI	50.17
RSI Monthly	51.32
RSI Weekly	40.43
Sharpe ratio	0.24x
Sortino ratio	0.38
Total Return	-3.94%
Tr YTD	-24.14
Tr1m	-4.35%
Tr3m	-12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -8.8M
Operating margin	-27.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	240,448,000%
Net Borrowing	3,691,911.1
Shares Insiders	53.35%
Shares Out	515,472,000
Shares Qo Q	0.39%
Shares Yo Y	3.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -4.3M
Average Volume	222,000x
Bv Per Share	0.11
CAPEX	HKD -1.2M
Ch1m	-4.35
Ch1y	-15.38
Ch3m	-12
Ch3y	79.35
Ch5y	251.1
Ch6m	-36.54
Change	1.54%
Change From Open	3.13
Close	0.33
Days Gap	-1.54
Depreciation Amortization	1,981,840
Dollar Volume	92,400
Earnings Date	2026-08-07
EBIT	HKD -8.8M
EBITDA	HKD -6.9M
EPS	HKD -0.01
F Score	2
FCF	HKD -4.3M
FCF EV Yield	-3.33x
FCF Per Share	HKD -0.01
Financing CF	5,243,562
Fiscal Year End	December
Founded	1,992
Investing CF	3,449,712
Is Primary Listing	1
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Ma150	0.4
Ma150ch	-17.4%
Ma20	0.33
Ma20ch	0.15%
Net CF	6,059,252
Next Earnings Date	2026-08-07
Open	0.32
Position In Range	100
Ppne	9,864,289.1
Price Date	2026-05-08
Ptbv Ratio	2.99
Relative Volume	1.3x
Revenue	31,472,499x
Tr6m	-36.54%
Volume	280,000
Z Score	7.67

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/8622 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/8622 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/8622?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+53.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.9%

Negative means the company is buying back shares.

Technical

HKG/8622 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.2

Neutral momentum band

Price vs 200-day MA

-16.3%

50/200-day relationship not available

Beta (5Y)

0.78

Less volatile than the market

Sharpe ratio

0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/8622

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/8622 stock rating?

hkg/8622 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/8622 analysis?

The full report lives at /stocks/hkg/8622/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/8622?

The latest report frames hkg/8622 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/8622 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.